In other countries
The same active substances on other registers, the same brand first.
- RiximyoBrazil · Sandoz do Brasil Indústria Farmacêutica LtdaSame brand
- Riximyo 100 MG Concentrado Para Solucion Para PerfusionSpain · 10 mg · concentrado para solución para perfusión · Sandoz GmbhSame brand
- Riximyo 500 MG Concentrado Para Solucion Para PerfusionSpain · 10 mg · concentrado para solución para perfusión · Sandoz GmbhSame brand
- RiximyoEuropean Union · Sandoz GmbHSame brand
- RiximyoCroatiaSame brand
- RiximyoItaly · Concentrato per soluzione per infusione · Sandoz GMBHSame brand
- Riximyo 100 mg, concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Sandoz GmbHSame brand
- Riximyo 500 mg, concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Sandoz GmbHSame brand
- RiximyoNew Zealand · Inj 500 mg per 50 ml vialSame brand
- RiximyoNew Zealand · Inj 10 mg per ml, 50 ml vialSame brand
- RiximyoNew Zealand · Inj 10 mg per ml, 10 ml vialSame brand
- Blitzima®Serbia · 500mg/50mL · koncentrat za rastvor za infuziju · Oktal Pharma DOO BeogradSame form
- Blitzima®Serbia · 100mg/10mL · koncentrat za rastvor za infuziju · Oktal Pharma DOO BeogradSame form
- Blitzima®Serbia · 100mg/10mL · koncentrat za rastvor za infuziju · Oktal Pharma DOO BeogradSame form
- RituxanUnited States · 100MG/10ML, 500MG/50ML · solution · GenentechSame form
- Bio-Manguinhos RituximabeBrazil · Fundação Oswaldo CruzSame substance
- MabtheraBrazil · Produtos Roche Químicos e Farmacêuticos S.A.Same substance
- Ituxredi 100 MG Concentrado Para Solucion Para PerfusionSpain · 100 mg · concentrado para solución para perfusión · Reddy Holding GmbhSame substance
- BlitzimaEuropean Union · Celltrion Healthcare Hungary Kft.Same substance
- ItuxrediEuropean Union · Reddy Holding GmbHSame substance
- MabTheraCroatiaSame substance
- RixathonCroatiaSame substance
- ItuxrediItaly · Concentrato per soluzione per infusione · Reddy Holding GMBHSame substance
- MabtheraItaly · Soluzione iniettabile · Roche Registration GMBHSame substance
- Blitzima 100 mg, concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor injectie of infusie · Celltrion Healthcare Hungary Kft.Same substance
- MABTHERA 100 mgRomania · 10mg/ml · conc. pt. sol. perf. · Roche Registration GMBHSame substance
- MABTHERA 1400 mgRomania · 120mg/ml · sol inj. · Roche Registration GMBHSame substance
- MABTHERA 1600 mgRomania · 120mg/ml · sol. inj. · Roche Registration GMBHSame substance
- Mabthera 10MG-1ML Conc. for I.V InfusionSaudi Arabia · Roche Diagnostics GmbHSame substance
- Mabthera 10MG-1ML Conc. for I.V InfusionSaudi Arabia · Roche Diagnostics GmbHSame substance
- Mabthera 119.4 MG Solution for Subcutaneous InjectionSaudi Arabia · F. Hoffmann-La Roche Ltd.Same substance
- Mabthera Concentrate for Solution for Infusion 100mg/10mlSingapore · 10mg/ml · infusion, solution concentrate · Roche Singapore Pte. LTD.Same substance
- MABTHERA CONCENTRATE FOR SOLUTION FOR INFUSION 500 mg/50mlSingapore · 10 mg/ml · injection · Roche Singapore Pte. LTD.Same substance
- Truxima® Concentrate for Solution for Infusion 10MG/MLSingapore · 10mg/mL · infusion, solution concentrate · Celltrion Healthcare Singapore Private LimitedSame substance
- RuxienceUnited States · 100MG/10ML, 500MG/50ML · injectable · Pfizer INCSame substance
- RiabniUnited States · 500MG/50ML · Injection · Amgen Inc.Same substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Rituximab
- Strength
- 10 MG / ML
- Dosage form
- Solution
- Route
- Intravenous
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 22 May 2020
- Registration
- DIN 02498316
- Marketing authorisation holder
- Sandoz Canada Incorporated
- ATC code
- L01FA01
- Supply
- PRESCRIPTION, SCHEDULE D